Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06136871 · ClinicalTrials.gov registry record · NA
Cognitive Rehabilitation in Post-COVID-19 Syndrome
A NA study of Post COVID-19 Syndrome, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT06136871: Completed NA study of Post COVID-19 Syndrome, sponsored by University of Missouri-Columbia.
NCT06136871 is a NA study of Post COVID-19 Syndrome that has completed, run by University of Missouri-Columbia. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06136871, a NA study of Post COVID-19 Syndrome, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
The first aim of this study is to determine the feasibility of delivering CO-OP remotely to individuals experiencing cognitive impairments that limit everyday activities in post-COVID-19 syndrome (PCS). The second aim of this study is to assess the effect of CO-OP on activity performance, subjective and objective cognition, and quality of life in a sample of individuals with PCS. The research team hypothesizes that effect size estimations will indicate that CO-OP will have a greater positive effect, compared to an inactive control group, on activity performance, subjective and objective cognition, and quality of life in a sample of individuals who self-report PCS and cognitive impairment.
Primary Outcome
Number of participants enrolled divided by number of individuals screened
Conditions Studied
Interventions
- BEHAVIORAL Inactive Control Group
- BEHAVIORAL CO-OP Procedures
Study Locations (1)
Missouri
- University of Missouri Department of Occupational Therapy - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
What the finished NCT06136871 record still lists
NCT06136871 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Post COVID-19 Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Inactive Control Group is the first listed.
NCT06136871 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06136871 about?
NCT06136871 is a clinical study titled "Cognitive Rehabilitation in Post-COVID-19 Syndrome". The first aim of this study is to determine the feasibility of delivering CO-OP remotely to individuals experiencing cognitive impairments that limit everyday activities in post-COVID-19 syndrome (PCS). The second aim of this study is to assess the effect of CO-OP on activity performance, subjective...
What is the current status of trial NCT06136871?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2024-02-01. Estimated completion is 2025-06-30.
What conditions does trial NCT06136871 study?
This clinical trial studies the following conditions: Post COVID-19 Syndrome.
What interventions are being tested in trial NCT06136871?
The interventions under investigation include: Inactive Control Group (BEHAVIORAL), CO-OP Procedures (BEHAVIORAL).
Who is sponsoring clinical trial NCT06136871?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06136871 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post COVID-19 Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06136871's enrollment target sits among peer trials
65 1144th of 2000 higher than 854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI